Where Next For Sesen Bio’s Bladder Cancer Therapy Vicineum?

First-Mover Hopes Dashed By CRL

 
• By Sten Stovall
CRL came just days before priority review target PDUFA date of 18 August. • Source: Alamy

More from Anticancer

More from Therapeutic Category